Skip to main content
Year archive

SHIELD THERAPEUTICS PLC — 2026 filings

All 18 regulatory filings released by SHIELD THERAPEUTICS PLC (STX) in 2026, sourced directly from the official regulator.

18 Filings
2026 Period
2026 filings (18)
Filing Released Lang
Total Voting Rights
Regulatory Filings
2026-05-29 English
Group of companies' accounts made up to 2025-12-31
Annual Report FY 2025
2026-05-29 English
Grant of Share Options
Director's Dealing
2026-05-05 English
Q1 2026 Trading Update
Interim / Quarterly Report Q1 2026
2026-05-01 English
Total Voting Rights
Regulatory Filings
2026-04-30 English
Enrollment in Phase II Clinical Trial for ACCRUFeR
Regulatory Filings
2026-04-27 English
Audited results for year ended 31 December 2025
Earnings Release FY 2025
2026-04-09 English
Publication of Report, Reinforcing FDA Approval
Report Publication Announcement
2026-04-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2026-03-31 English
EMA approves extension - to include adolescents
Regulatory Filings
2026-03-31 English
Chinese NMPA Accepts MAA Submission for ACCRUFeR®
Regulatory Filings
2026-03-03 English
Total Voting Rights
Regulatory Filings
2026-02-27 English
FDA Grants additional Exclusivity for ACCRUFeR
Regulatory Filings
2026-02-09 English
Total Voting Rights
Regulatory Filings
2026-01-30 English
Approval for ACCRUFeR in China expected in Q1 2026
Regulatory Filings
2026-01-30 English
Q4 2025 Trading Update
Earnings Release Q4 2025
2026-01-21 English
Block listing 6 Monthly Return
Regulatory Filings
2026-01-02 English
Total Voting Rights
Regulatory Filings
2026-01-02 English